Exploring BYON4413, A Novel CD123- targeting ByonZine ADC

Time: 11:00 am
day: Track B - Day 2


  • BYON4413 is an ADC directed against the molecular target CD123 (interleukin-3 receptor alpha chain), which is expressed on many hematologic malignancies
  • Introducing BYON4413 and its mechanism of action
  • Presenting the preclinical profile of BYON4413